Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Bacteriol. 2024 Oct 24;206(10):e0015124. doi: 10.1128/jb.00151-24. Epub 2024 Sep 11.
Small multidrug resistance (SMR) transporters are key players in the defense of multidrug-resistant pathogens to toxins and other homeostasis-perturbing compounds. However, recent evidence demonstrates that EmrE, an SMR from and a model for understanding transport, can also induce susceptibility to some compounds by drug-gated proton leak. This runs down the ∆pH component of the proton-motive force (PMF), reducing the viability of the affected bacteria. Proton leak may provide an unexplored drug target distinct from the targets of most known antibiotics. Activating proton leak requires an SMR to be merely present, rather than be the primary resistance mechanism, and dissipates the energy source for many other efflux pumps. PAsmr, an EmrE homolog from , transports many EmrE substrates in cells and purified systems. We hypothesized that PAsmr, like EmrE, may confer susceptibility to some compounds via drug-gated proton leak. Growth assays of expressing PAsmr displayed substrate-dependent resistance and susceptibility phenotypes, and solid-supported membrane electrophysiology experiments revealed that PAsmr performs both antiport and substrate-gated proton uniport, demonstrating the same functional promiscuity observed in EmrE. Growth assays of strain PA14 demonstrated that PAsmr contributes resistance to some antimicrobial compounds, but no growth defect is observed with susceptibility substrates, suggesting can compensate for the proton leak occurring through PAsmr. These phenotypic differences between and advance our understanding of the underlying resistance mechanisms in and prompt further investigation into the role that SMRs play in antibiotic resistance in pathogens.
Small multidrug resistance (SMR) transporters are a class of efflux pumps found in many pathogens, although their contributions to antibiotic resistance are not fully understood. We hypothesize that these transporters may confer not only resistance but also susceptibility, by dissipating the proton-motive force. This means to use an SMR transporter as a target; it merely needs to be present (as opposed to being the primary resistance mechanism). Here, we test this hypothesis with an SMR transporter found in and find that it can perform both antiport (conferring resistance) and substrate-gated proton leak. Proton leak is detrimental to growth in but not , suggesting that responds differently to or can altogether prevent ∆pH dissipation.
小分子多药耐药(SMR)转运蛋白是多药耐药病原体抵御毒素和其他破坏内稳态化合物的关键因素。然而,最近的证据表明,EmrE 是一种来自 的 SMR,也是理解转运的模型,也可以通过药物门控质子泄漏使某些化合物易感性增加。这会耗尽质子动力势(PMF)的 ∆pH 成分,降低受影响细菌的存活率。质子泄漏可能提供了一个未被探索的药物靶点,与大多数已知抗生素的靶点不同。激活质子泄漏仅需要 SMR 存在,而不是主要的耐药机制,并使许多其他外排泵的能量源耗散。PAsmr 是一种来自 的 EmrE 同源物,在细胞和纯化系统中转运许多 EmrE 底物。我们假设,与 EmrE 一样,PAsmr 可能通过药物门控质子泄漏使某些化合物易感性增加。表达 PAsmr 的 的生长测定显示出底物依赖性耐药和易感性表型,并且固态支持的膜电生理学实验表明,PAsmr 既能进行反向转运,也能进行底物门控质子单转运,表现出与 EmrE 观察到的相同的功能混杂性。PA14 菌株的生长测定表明,PAsmr 对一些抗菌化合物具有耐药性,但对易感性底物没有观察到生长缺陷,这表明 可以补偿通过 PAsmr 发生的质子泄漏。 与 之间的这些表型差异推进了我们对 中潜在耐药机制的理解,并促使进一步研究 SMR 在病原体抗生素耐药性中的作用。
小分子多药耐药(SMR)转运蛋白是许多病原体中发现的一类外排泵,尽管它们对抗生素耐药性的贡献尚未完全了解。我们假设这些转运蛋白不仅可以通过耗散质子动力势来赋予耐药性,还可以赋予易感性。这意味着使用 SMR 转运蛋白作为靶点,它只需要存在(而不是主要的耐药机制)。在这里,我们用在 中发现的 SMR 转运蛋白来测试这一假设,发现它既能进行反向转运(赋予耐药性),也能进行底物门控质子泄漏。质子泄漏对 的生长有害,但对 无害,这表明 对 ∆pH 耗散的反应不同,或者可以完全阻止 ∆pH 耗散。